229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.97%
Positive revenue growth while VUZI is negative. John Neff might see a notable competitive edge here.
-8.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
103.26%
EBIT growth above 1.5x VUZI's 11.13%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
103.26%
Operating income growth above 1.5x VUZI's 10.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
101.43%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
101.38%
EPS growth above 1.5x VUZI's 9.09%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
101.43%
Diluted EPS growth above 1.5x VUZI's 9.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.80%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-1.94%
Reduced diluted shares while VUZI is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.19%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-43.95%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-27.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
454.38%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
92.88%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
64.15%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-524.87%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-97.15%
Negative 3Y CAGR while VUZI is 36.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
290.54%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
112.65%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
45.42%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.87%
3Y dividend/share CAGR of 11.87% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
9.21%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
21.63%
We show growth while VUZI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
8.46%
Asset growth above 1.5x VUZI's 3.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.50%
We have a declining book value while VUZI shows 2.76%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
169.40%
We have some new debt while VUZI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-40.47%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
